Daflon 500 mg and venous leg ulcer: New results from a meta-analysis

Angiology

Volumn 56, Issue SUPPL. 1, 2005, Pages

  Smith, Philip Coleridge ^a,b,c  

^a Middlesex Hospital ^*

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c Thames Valley Nuffield Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DAFLON; PLACEBO;

CLINICAL TRIAL; COMPRESSION THERAPY; CONFERENCE PAPER; DISEASE DURATION; DOSE RESPONSE; HUMAN; LEG ULCER; META ANALYSIS; PROSPECTIVE STUDY; RISK REDUCTION; SYSTEMATIC REVIEW; TABLET; TREATMENT OUTCOME; ULCER HEALING; ARTICLE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE;

EID: 25444469934     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/00033197050560i106     Document Type: Conference Paper

References (26)

1. Ennis WJ, Meneses P: Standard, appropriate, and advanced care and medical-legal considerations: Part two-venous ulcerations. Wounds 15:107-122, 2003.
2. Scottish Leg Ulcer Trial Participants: Effect of a national community intervention programme on healing rates of chronic leg ulcer: Randomised controlled trial. Phlebology 17:47-53, 2002.
3. McMullin GM: Improving the treatment of leg ulcers. Med J Aust 175:375-378, 2001.
4. Lyseng-Williamson KA, Perry CM: Micronised purified flavonoid fraction. A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 63:71-100, 2003.
5. Shoab SS, Porter J, Scurr JH, et al: Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease - a prospective study. Eur J Vasc Endovasc Surg 17:313-318, 1999.
6. Blair SD, Wright DD, Backhouse CM, et al: Sustained compression and healing of chronic ulcers. BMJ 297:1151-1161, 1988.
7. Mayberry JC, Moneta GL, Taylor ML, et al: Fifteen-year results of ambulatory compression therapy for chronic venous ulcer. Surgery 109:575-581, 1991.
8. Jopp-McKay AG, Stacey MC, Rohr JB, et al: Out-patient treatment of chronic venous ulcers in a specialized clinic. Australas J Dermatol 32:143-149, 1991.
9. Moffatt CJ, Franks PJ, Oldroyd M, et al: Community clinics for leg ulcers and impact on healing. BMJ 305:1389-1392, 1992.
10. Erickson CA, Lanza DJ, Karp DL, et al: Healing of venous ulcers in an ambulatory care program: The roles of chronic venous insufficiency and patient compliance. J Vasc Surg 22:629-636, 1995.
11. Ghauri ASK, Nyamekye I, Grabs AJ, et al: Influence of a specialized leg ulcer service and venous surgery on the outcome of venous leg ulcers. Eur J Vasc Endovasc Surg 16:238-244, 1998.
12. Margolis DJ, Berlin JA, Strom BL: Risk factors associated with the failure of a venous ulcer to heal. Arch Dermatol 135:920-926, 1999.
13. Marston WA, Carlin RE, Passman MA, et al: Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency. J Vasc Surg 30:491-498, 1999.
14. Barwell JR, Ghauri ASK, Taylor M, et al: Risk factors for healing and recurrence of chronic venous leg ulcer. Phlebology 15:49-52, 2000.
15. Margolis DJ, Berlin JA, Strom BL: Which venous leg ulcers will heal with limb compression bandages? Am J Med 109:15-19, 2000.
16. Guilhou J-J, Dereure O, Marzin L, et al: Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomised, controlled versus placebo trial in 107 patients. Angiology 48:77-85, 1997.
17. Gliñski W, Chodynicka B, Roszkiewicz J, et al: The beneficial augmentative effect of micronised purified flavonoid fraction (MPFF) on the healing of leg ulcers: An open, multicentre, controlled, randomised study. Phlebology 14:151-157, 1999.
18. Roztocil K, Stvrtinova V, Strejcek J: Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency. Int Angiol 22:24-31, 2003.
19. Rieger H, Zuccarelli F: Clinical report (Lab Servier, France) on the effect of Daflon® 500 mg (2 tablets daily) on venous leg ulcers healing in 160 patients treated over a 6-month period. A multi-centre, double-blind, randomised, controlled versus placebo, parallel group study. Unpublished data.
20. Ming Keng T: Analysis report (Lab Servier, France) on the efficacy and acceptability of oral Daflon 500 mg in the healing of venous leg ulcers in Singaporean population of 134 patients. A 4-month, double-blinded, placebo-controlled study: Report prepared by Chan Siew Pang. Unpublished data.
21. Ulloa J: Double-blind, randomised, controlled versus placebo trial of Daflon 500 mg in venous leg ulcers in Latin America. Report (Lab Servier, France) prepared by Dr B. Detournay, S. Cros, A. Duburcq. Unpublished data.
22. Saveliev VS, Pokrovsky AV, Kirienko AI, et al: Analysis report (Lab Servier, France) of a randomised, multicentre comparative study of efficiency and safety of Detralex® in complementary treatment of complications of chronic venous insufficiency of lower extremities (trophic ulcers). Unpublished data.
23. Layton AM, Ibbotson SH, Davies JA, et al: Randomised trial of oral aspirin for chronic venous leg ulcers. Lancet 344:164-165, 1994.
24. Diehm C, Trampisch HJ, Lange S, et al: Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 347:292-294, 1996.
25. Ottillinger B, Greeske K: Rational therapy of chronic venous insufficiency-chances and limits of the therapeutic use of horse-chestnut seeds extract. BMC Cardiovasc Disord 1:5, 2001.
26. Wright DDI, Franks PJ, Blair SD, et al: Oxerutins in the prevention of recurrence in chronic venous ulceration: Randomised controlled trial. Br J Surg 78:1269-1270, 1991.